Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
370-01-009 ISMRM Abstract

Detecting early myelin damage linked to cognitive impairment before multiple sclerosis diagnosis

Primary: Neuro - White Matter
Secondary: Neuro - Multiple Sclerosis
370-01-009 · All About Neuroinflammation · Monday, 11 May, 8:20 AM–9:15 AM · Traditional Posters | Exhibition Hall
Keywords: Neurodegeneration Multiple Sclerosis Cognitive impairment Biomarker Myelin water imaging
Accepted
Olivia Kalau1, Sarah Morrow 2, Poljanka Johnson1, Irene M Vavasour1, Cornelia Laule1, Roger Tam1, Jeffrey Wilken3, Larry Lynd1, Scott Patten2, Yunyan Zhang2, Alexandre Prat4, Alan H Wilman5, Jiwon Oh6, Anthony Traboulsee1, Shannon Kolind1
1University of British Columbia, Vancouver, Canada
2University of Calgary, Calgary, Canada
3Georgetown University Hospital, Washington, United States of America
4University of Montreal, Montreal, Canada
5University of Alberta, Edmonton, Canada
6University of Toronto, Toronto, Canada
Presenting Author: Sarah Morrow

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139–1151. DOI: 10.1016/S1474-4422(08)70259-X [doi]
2. Granberg T, Martola J, Kristoffersen-Wiberg M, et al. Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler J 2013; 19: 271–280. DOI: 10.1177/1352458512451943 [doi]
3. Okuda DT, Siva A, Kantarci O, et al. Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event. PLOS ONE 2014; 9: e90509. DOI: 10.1371/journal.pone.0090509 [doi]
4. Amato MP, Hakiki B, Goretti B, et al. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 2012; 78: 309–314. DOI: 10.1212/WNL.0b013e31824528c9 [doi]
5. Lebrun C, Blanc F, Brassat D, et al. Cognitive function in radiologically isolated syndrome. Mult Scler J 2010; 16: 919–925. DOI: 10.1177/1352458510375707 [doi]
6. Abel S, Vavasour I, Lee LE, et al. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis. JAMA Netw Open 2020; 3: e2014220. DOI: 10.1001/jamanetworkopen.2020.14220 [doi]
7. Laule C, Moore GRW. Myelin water imaging to detect demyelination and remyelination and its validation in pathology. Brain Pathol 2018; 28: 750–764. DOI: 10.1111/bpa.12645 [doi]
8. Laule C, Leung E, Li DK, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler J 2006; 12: 747–753. DOI: 10.1177/1352458506070928 [doi]
9. Johnson P, Vavasour IM, Stojkova BJ, et al. Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis. J Neuroimaging 2023; 33: 227–234. DOI: 10.1111/jon.13069 [doi]
10. Oh J, Arbour N, Giuliani F, et al. The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design. BMC Neurol 2021; 21: 418. DOI: 10.1186/s12883-021-02447-7 [doi]
11. Prasloski T, Rauscher A, MacKay AL, et al. Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence. NeuroImage 2012; 63: 533–539. DOI: 10.1016/j.neuroimage.2012.06.064 [doi]
12. Doucette J, Kames C, Rauscher A. DECAES – DEcomposition and Component Analysis of Exponential Signals. Z Für Med Phys 2020; 30: 271–278. DOI: 10.1016/j.zemedi.2020.04.001 [doi]
13. Avants BB, Tustison N, Johnson H. Advanced Normalization Tools (ANTS). Insight j 2009; 2: 1–35. https://doi.org/10.54294/uvnhin [doi]
14. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004; 23: S208–S219. DOI: 10.1016/j.neuroimage.2004.07.051 [doi]
15. Valcarcel AM, Linn KA, Vandekar SN, et al. MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions. J Neuroimaging 2018; 28: 389–398. DOI: 10.1111/jon.12506 [doi]
16. Mori S, Wakana S, Zijl PCM van, et al. MRI Atlas of Human White Matter. Elsevier, 2005.
17. Rao SM, Losinski G, Mourany L, et al. Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting. Mult Scler J 2017; 23: 1929–1937. DOI: 10.1177/1352458516688955 [doi]
18. Rudick RA, Miller D, Bethoux F, et al. The Multiple Sclerosis Performance Test (MSPT): an iPad-based disability assessment tool. J Vis Exp JoVE 2014; e51318. DOI: 10.3791/51318 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/370-01-009